Your session is about to expire
← Back to Search
Licorice for Drug-Food Interaction
Phase 1
Waitlist Available
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 14 days
Awards & highlights
Study Summary
This study is evaluating whether a red clover dietary supplement is safe to use with FDA-approved drugs.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 14 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 14 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
1. Area Under the Curve (AUC)
Secondary outcome measures
1. Apparent Clearance
2. Peak Concentration
3. Time for Peak Concentration
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: G.GlabraExperimental Treatment5 Interventions
single arm
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dextromethorphan
FDA approved
Caffeine
FDA approved
Licorice
2008
Completed Phase 4
~340
Tolbutamide
FDA approved
Alprazolam
FDA approved
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
University of Illinois at ChicagoLead Sponsor
607 Previous Clinical Trials
1,559,337 Total Patients Enrolled
Oregon State UniversityOTHER
49 Previous Clinical Trials
8,362 Total Patients Enrolled
Richard vanBreemen, PhDStudy DirectorUniversity of Illinois at Chicago
1 Previous Clinical Trials
20 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger